Page last updated: 2024-12-11

amphoglucamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6449900
MeSH IDM0081856

Synonyms (5)

Synonym
n-methyl-d-glucamine amphotericin b
amphoglucomine
amphoglucamine
BMTUXPZRZGAUCT-LBUWUQBSSA-N
(1r,3s,5r,6r,9r,11r,15s,16r,17r,18s,19e,21e,23e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" After discontinuation of the drug use there were found elements of the fungi possibly due to insufficient dosage of the drug in the form of tablets."( [Our experience treating deep mycoses with amphoglucamine].
Moskovskaia, MA, 1981
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (83.33)18.7374
1990's1 (5.56)18.2507
2000's0 (0.00)29.6817
2010's2 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (9.52%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]